The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe
Open accessAbstract
BACKGROUND: The relative importance of human diseases is conventionally assessed by cause-specific mortality, morbidity, and economic impact. Current estimates for infections caused by antibiotic-resistant bacteria are not sufficiently supported by quantitative empirical data. This study determined the excess number of deaths, bed-days, and hospital costs associated with blood stream infections (BSIs) caused by methicillin-resistant Staphylococcus aureus (MRSA) and third-generation cephalosporin-resistant Escherichia coli (G3CREC) in 31 countries that participated in the European Antimicrobial Resistance Surveillance System (EARSS). METHODS AND FINDINGS: The number of BSIs caused by MRSA and G3CREC was extrapolated from EARSS prevalence data and national health care statistics. Prospective cohort studies, carried out in hospitals participating in EARSS in 2007, provided the parameters for estimating the excess 30-d mortality and hospital stay associated with BSIs caused by either MRSA or G3CREC. Hospital expenditure was derived from a publicly available cost model. Trends established by EARSS were used to determine the trajectories for MRSA and G3CREC prevalence until 2015. In 2007, 27,711 episodes of MRSA BSIs were associated with 5,503 excess deaths and 255,683 excess hospital days in the participating countries, whereas 15,183 episodes of G3CREC BSIs were associated with 2,712 excess deaths and 120,065 extra hospital days. The total costs attributable to excess hospital stays for MRSA and G3CREC BSIs were 44.0 and 18.1 million Euros (63.1 and 29.7 million international dollars), respectively. Based on prevailing trends, the number of BSIs caused by G3CREC is likely to rapidly increase, outnumbering the number of MRSA BSIs in the near future. CONCLUSIONS: Excess mortality associated with BSIs caused by MRSA and G3CREC is significant, and the prolongation of hospital stay imposes a considerable burden on health care systems. A foreseeable shift in the burden of antibiotic resistance from Gram-positive to Gram-negative infections will exacerbate this situation and is reason for concern.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
The global burden of typhoid fever.
(2004) · Europe PMC (PubMed Central) · Cited by 1,965
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Lambert, M.-L., Suetens, C., Savey, A., Palomar, M., Hiesmayr, M., Morales, I., Agodi, A., Frank, U., Mertens, K., Schumacher, M., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70258-9 · Cited by 443
Grundmann, H., Livermore, D. M., Giske, C. G., Cantón, R., Rossolini, G. M., Campos, J., Vatopoulos, A., Gniadkowski, M., Toth, A., Pfeifer, Y., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.46.19711-en · Cited by 284
Self-citationde Kraker, M. E. A., Wolkewitz, M., Davey, P. G., Koller, W., Berger, J., Nagler, J., Icket, C., Kalenic, S., Horvatic, J., Seifert, H., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq412 · Cited by 276
Self-citationde Kraker, M. E. A., Wolkewitz, M., Davey, P. G., & Grundmann, H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01157-10 · Cited by 240
Self-citationMcCormick, A. W., Whitney, C. G., Farley, M. M., Lynfield, R., Harrison, L. H., Bennett, N. M., Schaffner, W., Reingold, A., Hadler, J., Cieslak, P., et al. (2003) · Nature Medicine · doi:10.1038/nm839 · Cited by 222
Wyllie, D. H., Crook, D. W., & Peto, T. E. A. (2006) · BMJ · doi:10.1136/bmj.38834.421713.2f · Cited by 210
Econometric estimation of country-specific hospital costs
Adam, T., Evans, D. B., & Murray, C. J. (2003) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-1-3 · Cited by 202
Trends among pathogens reported as causing bacteraemia in England, 2004–2008
Wilson, J., Elgohari, S., Livermore, D. M., Cookson, B., Johnson, A., Lamagni, T., Chronias, A., & Sheridan, E. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03262.x · Cited by 174
Jones, R. N. (2003) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2003-37923 · Cited by 167
Benfield, T., Espersen, F., Frimodt-Møller, N., Jensen, A. G., Larsen, A. R., Pallesen, L. V., Skov, R., Westh, H., & Skinhøj, P. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01589.x · Cited by 161
Bender, R., & Blettner, M. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00510-8 · Cited by 141
Interhospital Differences in Nosocomial Infection Rates Importance of Case-Mix Adjustment
Sax, H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2437 · Cited by 98
Marchaim, D., Zaidenstein, R., Lazarovitch, T., Karpuch, Y., Ziv, T., & Weinberger, M. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0545-z · Cited by 72
Wolkewitz, M., Frank, U., Philips, G., Schumacher, M., Davey, P., on behalf of the BURDEN study group, Frank, U., Wilson, C., Lawrie-Blum, D., Kaier, K., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq424 · Cited by 72
Self-citationStaphylococcus aureus bacteraemia in Iceland, 1995–2008: changing incidence and mortality
Ásgeirsson, H., Guðlaugsson, Ó., Kristinsson, K. G., Heiðdal, S., & Kristjánsson, M. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03265.x · Cited by 45
Tong, E. N. C., Clements, A., Haynes, M. A., Jones, M., Morton, A., & Whitby, M. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-145 · Cited by 19
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Self-citationWill 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
de Kraker, M. E. A., Stewardson, A. J., & Harbarth, S. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002184 · Cited by 1,596
Self-citationInterventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub4 · Cited by 1,068
Self-citationAntimicrobial resistance: A global emerging threat to public health systems
Ferri, M., Ranucci, E., Romagnoli, P., & Giaccone, V. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077192 · Cited by 1,049
Metadata
- Authors
- de Kraker, M. E. A., Davey, P. G., Grundmann, H., & on behalf of the BURDEN study group
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-11
- Volume
- 8
- Issue
- 10
- Pages
- e1001104
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2050831884
- Cited by
- 599
- References
- 19
- FWCI
- 36.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.